| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/09/2009 | US20090093402 Albumin Fusion Proteins |
| 04/09/2009 | US20090093401 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents |
| 04/09/2009 | US20090093400 Truncated keratinocyte growth factor (KGF) having increased biological activity |
| 04/09/2009 | US20090093372 Methods for increasing definitive endoderm production |
| 04/09/2009 | US20090093366 Novel Herbicide Resistance Genes |
| 04/09/2009 | US20090093057 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 04/09/2009 | US20090093056 Adult Stem Cell-Derived Connective Tissue Progenitors for Tissue Engineering |
| 04/09/2009 | US20090093055 Islet Cells from Human Embryonic Stem Cells |
| 04/09/2009 | US20090093054 Transfer of hBS cells such as pluripotent human blastocyst-derived stem cell line from a fertilized oocyte to a feeder-free culture system and then propagating the cells in an undifferentiated state |
| 04/09/2009 | US20090093053 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 04/09/2009 | US20090093052 Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use |
| 04/09/2009 | US20090093051 T1R1 Nucleic Acid Sequences and Vectors Containing Same |
| 04/09/2009 | US20090093050 DNA Vaccine Enhancement with MHC Class II Activators |
| 04/09/2009 | US20090093040 producer cell which produces virions that contain the vector; comprises a minimal vector construct, a minimal packaging construct, and a minimal viral surface protein expression construct |
| 04/09/2009 | US20090093031 Ketoreductase Polypeptides for the Production of (R)-3-Hydroxythiolane |
| 04/09/2009 | US20090093026 TRANSDUCIBLE DELIVERY OF siRNA BY dsRNA BINDING DOMAIN FUSIONS TO PTD/CPPS |
| 04/09/2009 | US20090093015 Beta-cryptoxanthin production using a novel lycopene beta-monocyclase gene |
| 04/09/2009 | US20090093014 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 04/09/2009 | US20090093003 Porcine umami taste receptors and uses therefor |
| 04/09/2009 | US20090092992 Novel human dickkopf-related protein and nucleic molecules and uses therefor |
| 04/09/2009 | US20090092960 Novel Fluorescent and Colored Proteins, and Polynucleotides that Encode These Proteins |
| 04/09/2009 | US20090092703 Phytase-Expressing Transgenic Plants |
| 04/09/2009 | US20090092698 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 04/09/2009 | US20090092697 Extracts of polygonum multiflorum thunb., and preparation process and uses of the same |
| 04/09/2009 | US20090092653 Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
| 04/09/2009 | US20090092640 Increased T-cell tumor infiltration and eradication of metastases by mutant LIGHT |
| 04/09/2009 | US20090092638 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 04/09/2009 | US20090092627 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2009 | US20090092625 administering hematopoietic cells to increase blood platelet; for patient receiving cancer chemotherapy or radiation therapy, or immunosuppressants; treating blood disorders anemia, myeloma, non-Hodgkin's lymphoma, Hodgkins lymphoma and leukaemia |
| 04/09/2009 | US20090092623 Promoter |
| 04/09/2009 | US20090092616 ZNF206: A Novel Regulator of Embryonic Stem Cell Self-renewal and Pluripotency |
| 04/09/2009 | US20090092615 biodrugs select from an oligopeptide, or polypeptide; anticarcinogenic agent for treating lung cancer cell, adenocarcinoma cell; combination therapy using standard anti-cancer protocols in conjunction with Notch proteins |
| 04/09/2009 | US20090092613 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 04/09/2009 | US20090092612 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092607 Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 04/09/2009 | US20090092606 Antibacterial treatments |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092604 Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity |
| 04/09/2009 | US20090092601 HUMANIZED ANTI-LT-beta-R ANTIBODIES |
| 04/09/2009 | US20090092597 Mammalian cell surface antigens; related reagents |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092589 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/09/2009 | US20090092588 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease |
| 04/09/2009 | US20090092586 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype |
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092579 Novel method for down-regulation of amyloid |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | US20090092544 Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody |
| 04/09/2009 | US20090092543 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 04/09/2009 | CA2701907A1 Optimized and defined method for isolation and preservation of precursor cells from human umbilical cord |
| 04/09/2009 | CA2701624A1 Mutated acetohydroxyacid synthase genes in brassica |
| 04/09/2009 | CA2701435A1 Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
| 04/09/2009 | CA2701354A1 Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
| 04/09/2009 | CA2701048A1 Markers of endothelial cells and uses thereof |
| 04/09/2009 | CA2700617A1 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| 04/09/2009 | CA2700457A1 Neural tumor stem cells and methods of use thereof |
| 04/09/2009 | CA2699601A1 Nlrr-1 antagonists and uses thereof |
| 04/08/2009 | EP2045336A2 Characterisation of gene function using double stranded RNA inhibition |
| 04/08/2009 | EP2045329A1 Flagellin mutant vaccine |
| 04/08/2009 | EP2045328A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same |
| 04/08/2009 | EP2045322A1 Double-muscling in mammals |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2045262A1 Insecticidal proteins from bacillus thuringiensis |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044948A1 Methods and compositions concerning poxviruses and cancer |
| 04/08/2009 | EP2044197A1 Method of producing a population of cells |
| 04/08/2009 | EP2044196A2 A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells |
| 04/08/2009 | EP2044195A2 Matrix and method for isolation of hepatic progenitor cells |
| 04/08/2009 | EP2044122A2 Antagonist antibody against epha2 for the treatment of cancer |
| 04/08/2009 | EP2043686A2 Antagonists of protease activated receptor-1 (par1) |
| 04/08/2009 | EP2043666A2 Activated myeloid cells for promoting tissue repair and detecting damaged tissue |
| 04/08/2009 | EP2043662A2 Methods and compositions for treating disease |
| 04/08/2009 | EP1996937A4 Genetic packages and uses thereof |
| 04/08/2009 | EP1994140A4 Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture |
| 04/08/2009 | EP1907858A4 Compositions and methods for treating and diagnosing cancer |
| 04/08/2009 | EP1809736A4 Cryopreservation of cells |
| 04/08/2009 | EP1711598A4 Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof |
| 04/08/2009 | EP1559318B1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 04/08/2009 | EP1539808B1 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/08/2009 | EP1274854B1 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 04/08/2009 | EP1244692B1 Compositions and methods for detecting stress-inducible proteins |
| 04/08/2009 | EP1210092B1 Calcium-containing structures and methods of making and using the same |
| 04/08/2009 | EP1130961B1 Stabilisation of milk from transgenic animals |
| 04/08/2009 | CN101405404A Compositions, methods and systems for inferring bovine breed |
| 04/08/2009 | CN101405391A Water deficiency condition and abscisic acid induced transcription factor gene, promoter and transgenic plant in sunflower |
| 04/08/2009 | CN101405387A Method op assessing the viability of thawed cells |
| 04/08/2009 | CN101405384A Cell culture substrate |
| 04/08/2009 | CN101405298A Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 04/08/2009 | CN101402971A Transfection composition and transfection method for hogskin transfection |
| 04/08/2009 | CN101402970A Gene amplification method |
| 04/08/2009 | CN101402956A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402952A Low-frequency high-breadth overlapped high-frequency low-breadth loading method and bioreactor thereof |
| 04/08/2009 | CN101402943A Method for in vitro abduction and cultivation of multi-potentiality stem cell |
| 04/08/2009 | CN101402942A PolyLyse-HSP70 fusion protein film modified intestinal cancer cytoma vaccine and method of producing the same |
| 04/08/2009 | CN101402941A Method for amplifying Valpha24NKT cell from umbilical stalk blood |
| 04/08/2009 | CN101402940A Method for extracting plastocyte of mouse |
| 04/08/2009 | CN101402939A Method for increasing alkannin content of onosma paniculatum cultivation cell |
| 04/08/2009 | CN101402938A Method for producing protoplast |